GNE (gene): Difference between revisions
CSV import |
CSV import |
||
| Line 22: | Line 22: | ||
{{stub}} | {{stub}} | ||
{{No image}} | |||
Revision as of 17:56, 10 February 2025
GNE is a gene in humans that encodes the enzyme UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase. This enzyme is involved in the biosynthesis of sialic acids, which are important for a variety of biological functions.
Function
The GNE gene provides instructions for making an enzyme called UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase. This enzyme has two functions, each performed by a different region of the protein. The first part of the enzyme, known as the epimerase region, helps convert a molecule called UDP-N-acetylglucosamine to a molecule called N-acetylmannosamine. The second part of the enzyme, known as the kinase region, adds a phosphate group to N-acetylmannosamine to produce N-acetylmannosamine 6-phosphate. These reactions are the first steps in the production of a group of molecules called sialic acids.
Clinical significance
Mutations in the GNE gene are associated with GNE myopathy, a rare muscle disorder. This condition is characterized by progressive muscle weakness and wasting, primarily affecting the muscles in the legs. The condition is caused by a shortage of sialic acids in muscle cells, which affects the normal function of these cells.
See also
References
<references />


